Kinexum Quarterly and Conference Reports
The Kinexum Quarterly Report, produced by Kinexum business strategist Dr. Sam Collaudin, describes drug, biologics and device development programs in the field of diabetes and metabolism. Sam also produces summaries of certain conferenced during the year, such as the Advanced Technologies & Treatments for Diabetes (ATTD), American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD), Metabesity and Diabetes Technology Meeting (DTM) conferences. These reports reflect our mission to catalyze progress in the study of aging and the prevention and treatment of age-related chronic diseases, which include not only diabetes, obesity, cardiovascular diseases and NASH, but neurodegenerative diseases, cancer and the aging process itself.
Kinexum Quarterly Report – Q4 2021
Kinexum Quarterly Report – Q3 2021
